[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620414":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":22,"responsibleParty":37,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":10,"enrollmentInfo":49,"targetDuration":10,"studyType":52,"phases":10,"briefSummary":53,"conditions":54,"keywords":57,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Institut Curie","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Lung cancer",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Breast cancer",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Anne Bredart, Ph.D","CONTACT","+33 1 44 32 43 50","anne.bredart@curie.fr",{"name":20,"role":16,"phone":10,"phoneExt":10,"email":21},"Carole Cagnot","carole.cagnot@curie.fr",[23],{"facility":5,"status":24,"city":25,"state":10,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Paris","75005","France","FR",{"type":30,"coordinates":31},"Point",[32,33],2.3488,48.85341,{"lat":33,"lon":32},[36],{"name":15,"role":16,"phone":10,"phoneExt":10,"email":10},{"type":38,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100620414","screening-and-care-for-fear-of-cancer-recurrence-in-patients-with-cancer-at-institut-curie-100620414",false,"NCT07357311","Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie","Fear of Cancer Recurrence: Prevalence, Lived Experience and Satisfaction of Supportive Care Needs in the Hospital Care Pathway. A Mixed Method Study.","PDR-CARE","Inclusion Criteria:\n\n* Aged 18 or over\n* Clinical or pathological diagnosis of primary or recurrence of a localized\u002Floco-regional or metastatic breast cancer, or a stage 1 or 2, or stage 3 or 4 lung cancer; or a breast or lung cancer metastatic progression\n* Three months after completing treatment or three months after the start of a first treatment line for metastatic progression\n* Able to comply with the scheduled assessment and interviews\n* Able to read and understand the questionnaires' language (i.e. French)\n\nExclusion Criteria:\n\n* Participating in another patient-reported outcome study interfering with the present study\n* Any social, medical or psychological condition hindering questionnaire completion\n* Being deprived of personal liberty or under guardianship","ALL","18 Years",{"count":50,"type":51},200,"ESTIMATED","OBSERVATIONAL","The goals of this study is to establish the prevalence of severe forms of FCR in the oncology hospital setting, which will require a specific psychotherapeutic response. Two cancer sites are targeted: breast and pulmonary cancers. Secondary objectives include: 1) Determining threshold scores for the FCRI's 9-item severity scale for each type of cancer; 3) To identify a simple item from the FCRI for early detection of FCR in everyday clinical practice, especially using a digital format.",[55,56],"Lung Cancer","Breast Cancer",[58,59,9,12],"FCR","FoP","2026-01-21",{"date":62,"type":63},"2026-01-23","ACTUAL",{"date":65,"type":63},"2025-09-08",{"date":67,"type":51},"2027-12-31",{"name":5,"class":6},1]